Epigenetics and leukemia: Unraveling oncogenic processes in the BLV ovine model

Frontiers in Bioscience - Scholar

Volumn 1 S, Issue 1, 2009, Pages 154-163

  Merimi, Makram ^a   Ozkan, Yurda ^a   Cleuter, Yvette ^a   Griebel, Philip ^b   Burny, Arsene ^a   Martiat, Philippe ^a   Van Den Broeke, Anne ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Animal model; BLV; Epigenetic regulation; Leukemia; Review; Sheep; Tumor suppressor

Indexed keywords

ANIMAL; BOVINE LEUKEMIA VIRUS; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; LEUKEMIA; ONCOGENE; PATHOGENICITY; REVIEW; SHEEP; VIROLOGY; VIRUS GENE;

ANIMALS; EPIGENESIS, GENETIC; GENE SILENCING; GENES, VIRAL; LEUKEMIA; LEUKEMIA VIRUS, BOVINE; ONCOGENES; SHEEP;

EID: 77954462457     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/e15     Document Type: Article

References (96)

1. Burny A, Y Cleuter, R Kettmann, M Mammerickx, G Marbaix, D Portetelle, A Van den Broeke, L Willems, R Thomas: Bovin leukaemia: facts and hypotheses derived from the study of an infectious cancer Vet Microbiol 17, 197-197 (1988)
2. Willems L, R Kettmann, F Dequiedt, D Portetelle, V Voneche, I Cornil, P Kerkhofs, A Burny, M Mammerickx: I vivo infection of sheep by bovine leukemia virus mutants J Virol 67, 4078-4078 (1993)
3. Mammerickx M, R Palm, D Portetelle and A Burny: Experimenta transmission of enzootic bovine leukosis to sheep: latency period of the tumoral disease Leukemia 2, 103-103 (1988)
4. Willems L, A Burny, D Collete, O Dangoisse, F Dequiedt, J S Gatot, P Kerkhofs, L Lefebvre, C Merezak, T Peremans, D Portetelle, J C Twizere, R Kettmann: Geneti determinants of bovine leukemia virus pathogenesis AIDS Res Hum Retroviruses 16, 1787-1787 (2000)
5. Gillet N, A Florins, M Boxus, C Burteau, A Nigro, F Vandermeers, H Balon, A B Bouzar, J Defoiche, A Burny, M Reichert, R Kettmann, L Willems: Mechanism of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human Retrovirology 4, 18 (2007)
6. Schwartz I, A Bensaid, B Polack, B Perrin, M Berthelemy, D Levy: I vivo leukocyte tropism of bovine leukemia virus in sheep and cattle J Virol 68, 4589-4589 (1994)
7. Letesson JJ, A Mager, M Mammerickx, A Burny, A Depelchin: B cell from bovine leukemia virus (BLV) infected sheep with hematological disorders express the CD5 T cell marker Leukemia 4, 377-377 (1990)
8. Jeang KT, C Z Giam, F Majone, M Aboud: Life death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation J Biol Chem 279, 31991-31991 (2004)
9. Klener P, M Szynal, Y Cleuter, M Merimi, H Duvillier, F Lallemand, C Bagnis, P Griebel, C Sotiriou, A Burny, P Martiat, A Van den Broeke: Insight into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells J Virol 80, 1922-1922 (2006)
10. Szynal M, Y Cleuter, T Beskorwayne, C Bagnis, L C Van Lint, P Kerkhofs, A Burny, P Martiat, P Griebel, A Van den Broeke: Disruptio of B-cell homeostatic control mediated by the BLV-Tax oncoprotein: association with the upregulation of Bcl-2 and signaling through NF-kappaB Oncogene 22, 4531-4531 (2003)
11. Akagi T, H Ono, T Sasaki, K Shimotohno: Increase protein tyrosine-phosphorylation in primary T-cells transduced with Tax1 of human T-cell leukemia virus type I FEBS Lett 358, 34-34 (1995)
12. Willems L, H Heremans, G Chen, D Portetelle, A Billiau, A Burny, R Kettmann: Cooperatio between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation EMBO J 9, 1577-1577 (1990)
13. Ng PW, H Iha, Y Iwanaga, M Bittner, Y Chen, Y Jiang, G Gooden, J M Trent, P Meltzer, K T Jeang, S L Zeichner: Genome-wid expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation Oncogene 20, 4484-4484 (2001)
14. Marriott SJ, F J Lemoine, K T Jeang: Damaged DNA and miscounted chromosomes: human T cell leukemia virus type I tax oncoprotein and genetic lesions in transformed cells J Biomed Sci 9, 292-292 (2002)
15. Kettmann R, J Deschamps, Y Cleuter, D Couez, A Burny, G Marbaix: Leukemogenesi by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences Proc Natl Acad Sci U S A 79, 2465-2465 (1982)
16. Takeda S, M Maeda, S Morikawa, Y Taniguchi, J Yasunaga, K Nosaka, Y Tanaka, M Matsuoka: Geneti and epigenetic inactivation of tax gene in adult T-cell leukemia cells Int J Cancer 109, 559-559 (2004)
17. Van den Broeke A, C Bagnis, M Ciesiolka, Y Cleuter, H Gelderblom, P Kerkhofs, P Griebel, P Mannoni, A Burny: I vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wildtype tax gene J Virol 73, 1054-1054 (1999)
18. Van den Broeke A, Y Cleuter, G Chen, D Portetelle, M Mammerickx, D Zagury, M Fouchard, L Coulombel, R Kettmann, A Burny: Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells Proc Natl Acad Sci U S A
19. G Chen, D Portetelle, M Mammerickx, D Zagury, M Fouchard, L Coulombel, R Kettmann, A Burny: Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells Proc Natl Acad Sci U S A 85, 9263-9263 (1988)
20. Furukawa Y, R Kubota, M Tara, S Izuno, M Osame: Existence of escape mutant in HTLV-1 tax during the development of adult T-cell leukemia Blood
21. S Izuno, M Osame: Existence of escape mutant in HTLV-1 tax during the development of adult T-cell leukemia Blood, 109, 987-987 (2001)
22. Hanon E, R E Asquith, G P Taylor, Y Tanaka, J N Weber, C R Bangham: High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells AIDS Res Hum Retroviruses Asquith
23. G P Taylor, Y Tanaka, J N Weber, C R Bangham: High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells AIDS Res Hum Retroviruses 16, 1711-1711 (2000)
24. Powers MA, K Radke: Activatio of bovine leukemia virus transcription in lymphocytes from infected sheep: rapid transition through early to late gene expression J Virol 66, 4769-4769 (1992)
25. Bangham CR, M Osame: Cellula immune response to HTLV-1 Oncogene 24, 6035-6035 (2005)
26. Hanon E, S Hall, G P Taylor, M Saito, R Davis, Y Tanaka, K Usuku, M Osame, J N Weber, C R Bangham: Abundan tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes Blood 95, 1386-1386 (2000)
27. Merimi M, P Klener, M Szynal, Y Cleuter, C Bagnis, P Kerkhofs, A Burny, P Martiat, A Van den Broeke: Complet suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy: observations in Bovine Leukemia Virus-infected sheep Retrovirology 4, 51 (2007)
28. Merimi M, P Klener, M Szynal, Y Cleuter, P Kerkhofs, A Burny, P Martiat, A Van den Broeke: Suppressio of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code J Virol 81, 5929-5929 (2007)
29. Matsuoka M, K T Jeang: Huma T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation Nat Rev Cancer 7, 270-270 (2007)
30. Ego T, Y Ariumi, K Shimotohno: Th interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression Oncogene 21, 7241-7241 (2002)
31. Lemasson I, N J Polakowski, P J Laybourn, J K Nyborg: Tax-dependen displacement of nucleosomes during transcriptional activation of human T-cell leukemia virus type 1 J Biol Chem 281, 13075-13075 (2006)
32. Lu H, C A Pise-Masison, R Linton, H U Park, R L Schiltz, V Sartorelli, J N Brady: Ta relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat J Virol 78, 6735-6735 (2004)
33. Martin M, R Kettmann, F Dequiedt: Clas II a histone deacetylases: regulating the regulators Oncogene 26, 5450-5450 (2007)
34. Quivy V, C Calomme, A Dekoninck, D Demonte, F Bex, I Lamsoul, C Vanhulle, A Burny and L C Van Lint: Gen activation and gene silencing: a subtle equilibrium Cloning Stem Cells 6, 140-140 (2004)
35. Yang XJ, E Seto, HATs and HDACs: fro structure, function and regulation to novel strategies for therapy and prevention Oncogene 26, 5310-5310 (2007)
36. Lu H, C A Pise-Masison, T M Fletcher, R L Schiltz, A K Nagaich, M Radonovich, G Hager, P A Cole, J N Brady: Acetylation of nucleosomal histones by p300 facilitates transcription from tax-responsive human T-cell leukemia virus type 1 chromatin template Mol Cell Biol 22, 4450-4450 (2002)
37. Azran I, K T Jeang, M Aboud: High levels of cytoplasmic HTLV-1 Tax mutant proteins retain a Tax-NF-kappaB-CBP ternary complex in the cytoplasm Oncogene 24, 4521-4521 (2005)
38. Georges SA, H A Giebler, P A Cole, K Luger, P J Laybourn, J K Nyborg: Ta recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independent Mol Cell Biol 23, 3392-3392 (2003)
39. Calomme C, A Dekoninck, S Nizet, E Adam, T L Nguyen, B A Van den Broeke, L Willems, R Kettmann, A Burny, C Van Lint: Overlappin CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency J Virol and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency J Virol 78, 13848-13848 (2004)
40. Usui T, S Konnai, S Tajima, S Watarai, Y Aida, K Ohashi: Protectiv effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep J Vet Med Sci 65, 1201-5 (2003) (Pubitemid 41380044)
41. An W: Histon acetylation and methylation: combinatorial players for transcriptional regulation Subcell Biochem 41, 351-351 (2007)
42. Boultwood J, J S Wainscoat: Gen silencing by DNA methylation in haematological malignancies Br J Haematol 138, 3-3 (2007)
43. Sansom OJ, K Maddison, A R Clarke: Mechanism of disease: methyl-binding domain proteins as potential therapeutic targets in cancer Nat Clin Pract Oncol 4, 305-305 (2007)
44. Kharas MG, D A Fruman: AB oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors Cancer Res, 65, 2047-2047 (2005)
45. Rossetti S, A T Hoogeveen, P Liang, C Stanciu, S P van der Spek, N Sacchi: A distinct epigenetic signature at targets of a leukemia protein BMC Genomics 8, 38 (2007)
46. Roman-Gomez J, A Jimenez-Velasco, M Barrios, F Prosper, A Heiniger, A Torres and X Agirre: Poo prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes Leuk Lymphoma 48, 1269-1269 (2007)
47. Kim KR, T Yoshizaki, H Miyamori, K Hasegawa, T Horikawa, M Furukawa, Harada, M Seiki, H Sato: Transformatio of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth Oncogene 19, 1764-1764 (2000)
48. Chisari FV, C Ferrari: Hepatiti B virus immunopathology Springer Semin Immunopathol 17, 261-261 (1995)
49. Ryningen A, C Stapnes, O Bruserud: Clonogeni acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting Leuk Res 31, 1303-1303 (2007)
50. Yu MK: Epigenetic and chronic lymphocytic leukemia Am J Hematol 81, 864-864 (2006)
51. Ghoshal K, S Bai, DNA methyltransferases as targets for cancer therapy Drugs Today (Barc) 43, 395-395 (2007)
52. Kihslinger JE, L A Godley: Th use of hypomethylating agents in the treatment of hematologic malignancies Leuk Lymphoma 48, 1676-1676 (2007)
53. Griffiths EA, S D Gore: DN methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes Semin Hematol 45, 23-23 (2008)
54. Petrie K, N Prodromou, A Zelent: Histon deacetylase inhibitors in APL and beyond Curr Top Microbiol Immunol 313, 157-157 (2007)
55. Plass C, J C Byrd, A Raval, S M Tanner, C A de la Chapelle: Molecula profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes Br J Haematol 139, 744-744 (2007)
56. Raval A, J C Byrd, C Plass: Epigenetic in chronic lymphocytic leukemia Semin Oncol 33, 157-157 (2006)
57. Pui CH, W E Evans: Acute lymphoblastic leukemia N Engl J Med 339, 605-605 (1998)
58. Melki JR, S J Clark: DNA methylation changes in leukaemia Semin Cancer Biol 12, 347-347 (2002)
59. Schmidt WM, R Sedivy, B Forstner, G G Steger, S Zochbauer-Muller, R M Mader: Progressiv up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence Mol Carcinog 46, 766-766 (2007)
60. Ting AH, K W Jair, H Suzuki, R W Yen, S B Baylin, K E Schuebel: Mammalia DNA methyltransferase 1: inspiration for new directions Cell Cycle 3, 1024-1024 (2004)
61. Brenner C, F Fuks: DN methyltransferases: facts, clues, mysteries Curr Top Microbiol Immunol 301, 45-45 (2006)
62. Fuks F: DN methylation and histone modifications: teaming up to silence genes Curr Opin Genet Dev 15, 490-490 (2005)
63. Fuks F, P J Hurd, D Wolf, X Nan, A P Bird, T Kouzarides: The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation J Biol Chem 278, 4035-4035 (2003)
64. Wozniak RJ, W T Klimecki, S S Lau, Y Feinstein, B W Futscher: 5-Aza-2'-deoxycytidine-mediate reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation Oncogene 26, 77-77 (2007)
65. Mai A, S Massa, D Rotili, I Cerbara, S Valente, R Pezzi, S Simeoni, R Ragno: Histon deacetylation in epigenetics: an attractive target for anticancer therapy Med Res Rev 25, 261-261 (2005)
66. Tao Q, K D Robertson: Stealt technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection Clin Immunol 109, 53-53 (2003)
67. Tsai CL, H P Li, Y J Lu, C Hsueh, Y Liang, C L Chen, S W Tsao, K P Tse, J S Yu, Y S Chang: Activatio of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH (2)-terminal kinase signaling Cancer Res 66, 11668-11668 (2006)
68. Burgers WA, L Blanchon, S Pradhan, L Y de Launoit, T Kouzarides, F Fuks: Vira oncoproteins target the DNA methyltransferases Oncogene 26, 1650-1650 (2007)
69. Jung JK, P Arora, J S Pagano, K L Jang: Expressio of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway Cancer Res 67, 5771-5771 (2007)
70. Hellebrekers DM, V Melotte, E Vire, E Langenkamp, G Molema, F Fuks, J G Herman, C W Van, A W Griffioen, E M van England: of epigenetically silenced genes in tumor endothelial cells Cancer Res 67, 4138-4138 (2007)
71. Karpf AR: Epigenomic reactivation screening to identify genes silenced by DNA hypermethylation in human cancer Curr Opin Mol Ther 9, 231-231 (2007)
72. Zhu WG, G A Otterson: The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells Curr Med Chem Anticancer Agents 3, 187-187 (2003)
73. Kantarjian HM: Recent experience with decitabine in MDS Clin Adv Hematol Oncol 5, 140 (2007) (Pubitemid 46455273)
74. Plimack ER, H M Kantarjian, J P Issa: Decitabine and its role in the treatment of hematopoietic malignancies Leuk Lymphoma 48, 1472-1472 (2007)
75. Garcia-Manero G, H I Saba: Decitabine in myelodysplastic syndromes: viewpoints Drugs 66, 959-959 (2006)
76. Soriano AO, H Yang, S Faderl, Z Estrov, F Giles, F Ravandi, J Cortes, W G Wierda, S Ouzounian, A Quezada, S Pierce, E H Estey, J P Issa, H M Kantarjian, G Garcia-Manero: Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and alltrans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome Blood 110, 2302-2302 (2007)
77. Sigalotti L, E Fratta, S Coral, E Cortini, A Covre, H J Nicolay, L Anzalone, L Pezzani, A M Di Giacomo, E Fonsatti, F Colizzi, M Altomonte, L Calabro and M Maio: Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications J Cell Physiol 212, 330-330 (2007)
78. Achachi A, A Florins, N Gillet, C Debacq, P Urbain, G M Foutsop, F Vandermeers, A Jasik, M Reichert, P Kerkhofs, L Lagneaux, A Burny, R Kettmann, L Willems: Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo Proc Natl Acad Sci U S A 102, 10309-10309 (2005)
79. Kurdistani SK: Histone modifications as markers of cancer prognosis: a cellular view Br J Cancer 97, 1-1 (2007)
80. Hata K, K Nishijima, J Mizuguchi: Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement Exp Cell Res 313, 2356-2356 (2007)
81. Jiang HY, R C Wek: Phosphorylation of the alphasubunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition J Biol Chem 280, 14189-14189 (2005)
82. Kawakubo H, J L Carey, E Brachtel, V Gupta, J E Green, P D Walden, S Maheswaran: Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer Oncogene 23, 8310-8310 (2004)
83. Passeri D, A Marcucci, G Rizzo, M Billi, M Panigada, L Leonardi, F Tirone and F Grignani: Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation Mol Cell Biol 26, 5023-5023 (2006)
84. Rush LJ, A Raval, P Funchain, A J Johnson, L Smith, D M Lucas, M Bembea, T H Liu, N A Heerema, L Rassenti, S Liyanarachchi, R Davuluri, J C Byrd, C Plass: Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets Cancer Res 64, 2424-2424 (2004)
85. Sabbioni S, A Veronese, M Trubia, R Taramelli, G Barbanti-Brodano, C M Croce and M Negrini: Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD Cytogenet Cell Genet 86, 214-214 (1999)
86. Wang L, S Takaku, P Wang, D Hu, S Hyuga, T Sato, S Yamagata, T Yamagata: Ganglioside GD1a regulation of caveolin-1 and Stim1 expression in mouse FBJ cells: augmented expression of caveolin-1 and Stim1 in cells with increased GD1a content Glycoconj J 23, 303-303 (2006)
87. Carro MS, F M Spiga, M Quarto, N Di, V, S Volorio, M Alcalay, H Muller: DEK expression is controlled by E2F and deregulated in diverse tumor types Cell Cycle 5, 1202-1202 (2006)
88. Contri A, A M Brunati, L Trentin, A Cabrelle, M Miorin, L Cesaro, L A Pinna, R Zambello, G Semenzato, A Donella-Deana: Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis J Clin Invest 115, 369-369 (2005)
89. Hollenbach AD, C J McPherson, E J Mientjes, R Iyengar, G Grosveld: Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek J Cell Sci 115, 3319-3319 (2002)
90. Tedoldi S, J C Paterson, J Cordell, S Y Tan, M Jones, S Manek, A P Dei Tos, H Roberton, N Masir, Y Natkunam, S A Pileri, F Facchetti, M L Hansmann, D Y Mason, T Marafioti: Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas J Pathol 209, 454-454 (2006)
91. Polson AG, S F Yu, K Elkins, B Zheng, S Clark, G S Ingle, D S Slaga, L Giere, C Du, C Tan, J A Hongo, A Gogineni, M J Cole, R Vandlen, J P Stephan, J Young, W Chang, S J Scales, S Ross, D Eaton, A Ebens: Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma Blood 110, 616-616 (2007)
92. Chu PG, D A Arber: CD79: a review Appl Immunohistochem Mol Morphol 9, 97-97 (2001)
93. Winquist E, J Knox, J P Ayoub, L Wood, N Wainman, G K Reid, L Pearce, A Shah, E Eisenhauer: Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug study Invest New Drugs 24, 159-159 (2006)
94. Oridate N, R Lotan: Suppression of DNA methyltransferase 1 levels in head and neck squamous carcinoma cells using small interfering RNA results in growth inhibition and increase in Cdk inhibitor p21 Int J Oncol 26, 757-757 (2005)
95. Griebel PJ, T Beskorwayne, D L Godson, Y Popowych, W Hein: Cloning non-transformed sheep B cells J Immunol Methods 237, 19-19 (2000)
96. Moules V, C Pomier, D Sibon, A S Gabet, M Reichert, P Kerkhofs, L Willems, F Mortreux, E Wattel: Fate of premalignant clones during the asymptomatic phase preceding lymphoid malignancy Cancer Res 65, 1234-1234 (2005)